Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q30392632)
Watch
English
Rimonabant: obituary for a wonder drug
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
title
Rimonabant: obituary for a wonder drug
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
genre
obituary
0 references
author name string
S Matthijs Boekholdt
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
Ron J G Peters
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
language of work or name
English
0 references
publication date
1 August 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
volume
376
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
issue
9740
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
page(s)
489-490
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
cites work
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961080-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(10)61080-X
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
PubMed ID
20709215
1 reference
stated in
Europe PubMed Central
PubMed ID
20709215
retrieved
21 June 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
